Navigation Links
Comprehensive biodefense text published

A new book, Biological Weapons Defense: Infectious Disease and Counterbioterrorism, deals with the intentional causality of disease. Published by Humana Press, this text is also available in e-Book. Many of the contributors come from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the nation's premier biodefense laboratory.

In this 624-page, hardcover text edited by Luther E. Lindler, Frank J. Lebeda, and George W. Korch, biodefense research experts authoritatively explain the universe of scientific, medical, and legal issues facing the biodefense research community. They describe the origin, effects and treatment of established pathogens that cause diseases such as anthrax, plague, smallpox, brucellosis, glanders, and Q fever, and discuss what is known about the aerosol route of infection and the process of decontamination.

Contained in the 25 chapters is an extensive discussion of preparation and military support for possible acts of bioterrorism, medical count

ermeasures, emerging threats and future preparation, and development of diagnostic tests for identifying biological warfare pathogens. Intended for researchers, physicians, and policy makers, Biological Weapons Defense: Infectious Disease and Counterbioterrorism offers a detailed look at the ongoing efforts to detect and identify these disease-causing agents, including proteomic and genomic analysis as a gateway to better diagnostics, therapeutics, vaccinations, genotyping, and forensics.


'"/>

Source:US Army Medical Research Institute of Infectious Diseases


Page: 1

Related biology news :

1. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
2. Comprehensive model is first to map protein folding at atomic level
3. Disease diagnosis, biodefense among UH chemical research projects
4. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
5. Genomic comparison of lactic acid bacteria published
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... -- AIC announces that it has just released a new white paper authored by Zettar ... high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced today the ... KbioBox developed a sophisticated “3 click” gene dditing off target analysis program and ... website, https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selector™ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
(Date:12/7/2016)... Dec. 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), ... commercialization of immunotherapeutic products for the treatment of ... an Antibody Manufacturing Development Program with Cytovance Biologics ... for its oregovomab antibody product. Supported by recent ... clinical study in ovarian cancer patients, OncoQuest has ...
Breaking Biology Technology: